Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if CDIO is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
3 top institutions tracked
Sentiment: unknown
No recent insider trades detected.
Red flags: 9
17 filers reported a long position in CDIO for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $107.7K | 49.2K | +220.6% |
| BlackRock, Inc. | $76K | 34.7K | Unchanged |
| GEODE CAPITAL MANAGEMENT, LLC | $57.4K | 26.2K | -18.5% |
| VANGUARD CAPITAL MANAGEMENT LLC | $44.1K | 20.2K | Unchanged |
| CITADEL ADVISORS LLC | $41.8K | 19.1K | New |
| XTX Topco Ltd | $35.2K | 16.1K | New |
| JANE STREET GROUP, LLC | $26.1K | 11.9K | -85.3% |
| STATE STREET CORP | $22.1K | 10.1K | New |
| VANGUARD FIDUCIARY TRUST CO | $6.2K | 2.8K | -28.8% |
| Tower Research Capital LLC (TRC) | $4K | 1.8K | -17.5% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.